Tilisolol: Difference between revisions
Appearance
Content deleted Content added
populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot |
|||
(16 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = |
||
| IUPAC_name = (''RS'')-4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methylisoquinolin-1-one |
| IUPAC_name = (''RS'')-4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methylisoquinolin-1-one |
||
| image = Tilisolol.svg |
| image = Tilisolol.svg |
||
| |
| = mixture |
||
| drug_name = |
| drug_name = |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
Line 27: | Line 27: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 85136-71-6 |
| CAS_number = 85136-71-6 |
||
| CAS_supplemental = <br/>{{CAS|62774-96-3}} ([[hydrochloride]]) |
| CAS_supplemental = <br/>{{CAS|62774-96-3}} ([[hydrochloride]]) |
||
Line 39: | Line 40: | ||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D08598 |
| KEGG = D08598 |
||
| ChemSpiderID = 5275 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=17 | H=24 | N=2 | O=3 |
| C=17 | H=24 | N=2 | O=3 |
||
| molecular_weight = 304.38 g/mol |
|||
| smiles = CC(C)(C)NCC(COC1=CN(C(=O)C2=CC=CC=C21)C)O |
| smiles = CC(C)(C)NCC(COC1=CN(C(=O)C2=CC=CC=C21)C)O |
||
| StdInChI = 1S/C17H24N2O3/c1-17(2,3)18-9-12(20)11-22-15-10-19(4)16(21)14-8-6-5-7-13(14)15/h5-8,10,12,18,20H,9,11H2,1-4H3 |
|||
| StdInChIKey = TWVUMMQUXMYOOH-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Tilisolol''' ([[International Nonproprietary Name|INN]], trade name '''Selecal''') is a [[beta blocker]]. |
'''Tilisolol''' ([[International Nonproprietary Name|INN]], trade name '''Selecal''') is a [[beta blocker]]. |
||
==Synthesis== |
|||
[[File:Tilisolol synthesis.svg|center|500px|thumb|[https://pharmaceutical-substances.thieme.com/ps/search-results?docUri=KD-20-0089 Thieme] [https://www.chemdrug.com/article/8/3284/16419653.html ChemDrug] Synthesis:<ref>Serradell, MN; Blancafort, P.; Thorpe, PJ; Castaer, J.; N-696. Drugs Fut 1982, 7, 12, 889.</ref> Patent:<ref>Hideo Saitama Jp Fukushima, Yoshikuni Kawagoe Saitama Jp Suzuki, DE2631080 (1985 to Nisshin Flour Milling Co., Ltd., Tokio / Tokyo, Jp).</ref> Precursor:<ref>Lombardino, J. G. (October 1970). "Synthesis of 4‐hydroxy‐2‐methylisocarbostyril‐3‐carboxanilides". Journal of Heterocyclic Chemistry. 7 (5): 1057–1060. doi:10.1002/jhet.5570070509.</ref> Sino:<ref>Li Leilei, et al. CN102115459 (2011 to Dihon Pharmaceutical Group Co Ltd).</ref> HPLC:<ref>Yonezawa K, Sato K, Kobayashi A. High-performance liquid chromatography of a new beta-blocker, 4-[3-(tert.-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride, in plasma using fluorometric detection. J Chromatogr. 1985 Apr 12;339(1):219-22. doi: 10.1016/s0378-4347(00)84648-4. PMID: 2862154.</ref>]] |
|||
The methanolysis of Phthalic anhydride [85-44-9] (1) gives Methyl hydrogen phthalate [4376-18-5] (2). Schotten-Baumann amidation with Methyl sarcosinate [5473-12-1] (3) gives Methyl 2-[(2-methoxy-2-oxoethyl)-methylcarbamoyl]benzoate, PC11644670 (4). Intramolecular lactamization with sodium methoxide afforded Methyl 4-hydroxy-2-methyl-1-oxoisoquinoline-3-carboxylate, PC54684295 (5). In lye saponification followed by decarboxylation occurred to give 4-hydroxy-2-methylisoquinolin-1(2H)-one [30236-50-1] (6). Treatment with Epichlorhydrin [106-89-8] (7) in the presence of base led to 2-Methyl-4-[(oxiran-2-yl)methoxy]isoquinolin-1(2H)-one [62775-08-0] (8). Opening of the oxirane ring with tert-Butylamine [75-64-9] (9) completed the synthesis of Tilisolol (10). |
|||
== References == |
|||
{{Reflist}} |
|||
{{Beta blockers}} |
{{Beta blockers}} |
||
Line 53: | Line 62: | ||
[[Category:Isoquinolines]] |
[[Category:Isoquinolines]] |
||
[[Category:Phenol ethers]] |
[[Category:Phenol ethers]] |
||
[[Category: |
[[Category:]] |
||
[[Category:Amines]] |
|||
[[Category:Tert-butyl compounds]] |
|||
{{antihypertensive-stub}} |
{{antihypertensive-stub}} |